In Re Relafen Antitrust Litigation

SUPPLEMENTAL MEMORANDUM CLARIFYING THE PRESENT STATUS OF THESE PROCEEDINGS AND SETTING FORTH THE LEGAL FRAMEWORK FOR FURTHER JUDICIAL ACTION

YOUNG, Chief Judge.

I. INTRODUCTION

This case is a consolidated action against SmithKline Beeeham Corporation and GlaxoSmithKline PLC (collectively “Smith-Kline”) by multiple parties. The plaintiffs include SmithKline competitor Eon Labs; pharmaceutical wholesalers that purchased Relafen directly from SmithKline (“direct purchasers”); drugstores that indirectly purchased Relafen and the generic drug nabumetone for resale (“drugstore plaintiffs”); and…